Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
2011
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study
2010
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
2024 StandoutNobel
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
2008
Preventive therapy for breast cancer: a consensus statement
2011
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
Triple negative breast cancer: unmet medical needs
2010
Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
2010
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
2008
Biologic markers determine both the risk and the timing of recurrence in breast cancer
2011
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Two-tier supramolecular encapsulation of small molecules in a protein cage
2020
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Cell Metabolism
2011
A view on drug resistance in cancer
2019 StandoutNature
Oct4 pseudogenes are transcribed in cancers
2005
Breast cancer
2016 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
The perivascular niche regulates breast tumour dormancy
2013
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
2008 StandoutNature
Sentinel node biopsy in male breast cancer
2004
Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues
2005
Glycosylation inhibitors in biology and medicine
1995
Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†
2002
Embryonic transcription factors in human breast cancer
2006
Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity
2009
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Efficacy of Anastrozole in Male Breast Cancer
2002
Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer
2015
Breast carcinoma in men
2004 Standout
Metastasis prevention by targeting the dormant niche
2015
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
Clinical relevance of biologic factors in male breast cancer
2001
Adjuvant radiotherapy in male breast cancer
1999
Tumor metastasis: moving new biological insights into the clinic
2013
Breast Cancer Metastasis
2013
VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
2011
Glycoprotein glycosylation and cancer progression
1999
Regulation of cancer cell metabolism
2011 Standout
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
2017
Male breast cancer
2006 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
2008
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Glycosidases of the asparagine-linked oligosaccharide processing pathway
1994
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
2009
Experiences of men with breast cancer: an exploratory focus group study
2003
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Targeting metastasis
2016
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
A preliminary study of the role of extracellular -5′- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition
2016
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay
2002
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
2012
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
2006
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer
2003
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)
2009
Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?
2014
Adjuvant systemic therapy for male breast carcinoma
2005
Perspectives on the significance of altered glycosylation of glycoproteins in cancer
1997
Therapeutic potential of PARP inhibitors for metastatic breast cancer
2011
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1
2015
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Cancer du sein chez l’homme : à propos de 19 cas
2002
Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
2014
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
2007 StandoutNature
Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities
2010
Male breast cancer in the veterans affairs population
2007
Preservation of Fertility in Patients with Cancer
2009 Standout
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
2013
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
2012
Trends in mortality from major cancers in the Americas: 1980–2010
2014
The cancer genome
2009 StandoutNature
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Organelle-specific initiation of cell death pathways
2001
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Organocatalytic Asymmetric Mannich Reactions: New Methodology, Catalyst Design, and Synthetic Applications
2007
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover
2011
Development and Applications of Disulfonimides in Enantioselective Organocatalysis
2015 StandoutNobel
Breast Cancer Treatment
2019 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Profiling global cancer incidence and mortality by socioeconomic development
2020
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Intracellular Functions of N-Linked Glycans
2001 StandoutScience
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Strategies in treating male breast cancer
2007
A Chemical Reporter Strategy to Probe Glycoprotein Fucosylation
2006 StandoutNobel
Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
2012
Cancer Genome Landscapes
2013 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Imaging the glycome
2008 StandoutNobel
How to treat male breast cancer
2007
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Global cancer statistics, 2012
2015 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse
2006
Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy*
2003
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
2012
Breast Cancer in Men
2002 Standout
Works of Paul E. Goss being referenced
Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study
2013
TEACH: Tykerb Evaluation After Chemotherapy
2007
Lapatinib
2007
Letrozole in the extended adjuvant setting: MA.17
2007
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
2013
Examination ofPOU homeobox gene expression in human breast cancer cells
1999
Current perspectives on aromatase inhibitors in breast cancer.
1994
Breast cancer in China
2014
The role of COX-2 inhibition in breast cancer treatment and prevention
2004
Branching N-Linked Oligosaccharides in Breast Cancer
1994
National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women
2007
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
2008
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
2013
Male breast carcinoma
1999
The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial
2007
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
2016
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer
2013
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
2011
Does tumour dormancy offer a therapeutic target?
2010
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
2005
Preventing Relapse Beyond 5 Years: The MA.17 Extended Adjuvant Trial
2006
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial
2006
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
2008
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
1998
Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer
1999
Inhibitors of carbohydrate processing: A new class of anticancer agents.
1995
P119 Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with ErbB2-overexpressing breast cancer: Tykerb evaluation after chemotherapy (TEACH) study
2007
Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8
2000
Advances in Adjuvant Hormonal Therapy for Postmenopausal Women
2005
A phase II trial of the PARP inhibitor veliparib (ABT888) and temozolomide for metastatic breast cancer.
2010
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
2008
Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA17 Trial.
2009
Lapatinib: Current Status and Future Directions in Breast Cancer
2006
The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells
2003
A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
2016
Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer
2003
A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
2004